Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E J Neufeld

Showing results (1-10 of 79) with videos related to

Pageof 8
Sort By:
Hematology/Oncology Clinics of North America|January 29, 1999
Update on genetic risk factors for thrombosis and atherosclerotic vascular diseaseE J Neufeld
Current Opinion in Pediatrics|December 1, 1993
Inherited dyslipidemias in childhoodE J Neufeld
Archives of Biochemistry and Biophysics|June 1, 1978
A mutant fibroblast cell line defective in glycoprotein synthesis due to a deficiency of glucosamine phosphate acetyltransferaseE J Neufeld, I Pastan
Hematology/Oncology Clinics of North America|January 29, 1999
Hemophilia. A new approach to an old diseaseD DiMichele, E J Neufeld
The Journal of Biological Chemistry|February 25, 1983
Arachidonate release and phosphatidic acid turnover in stimulated human plateletsE J Neufeld, P W Majerus
Biochemical and Biophysical Research Communications|January 15, 1993
Sequence-specific binding of HMG-I (Y) to the proximal promoter of the gp91-phox geneD G Skalnik, E J Neufeld
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 10, 2015
Transition considerations for extended half-life factor productsS E Croteau, E J Neufeld
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 6, 2015
Author's response: 'Transition considerations for extended half-life factor products'S E Croteau, E J Neufeld
Biochemical and Biophysical Research Communications|September 16, 1992
Sequence-specific binding of HMG-I(Y) to the proximal promoter of the gp91-phox geneD G Skalnik, E J Neufeld
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 15, 2014
Correlation between dispensed and prescribed doses of factor products for bleeding disorders: can a small, centre-based pharmacy hit the mark?S E Croteau, K Saxena, E J Neufeld
Pageof 8

Showing results (1-10 of 79) with videos related to

Sort By:
Pageof 8
Hematology/Oncology Clinics of North America|January 29, 1999
Update on genetic risk factors for thrombosis and atherosclerotic vascular diseaseE J Neufeld
Current Opinion in Pediatrics|December 1, 1993
Inherited dyslipidemias in childhoodE J Neufeld
Archives of Biochemistry and Biophysics|June 1, 1978
A mutant fibroblast cell line defective in glycoprotein synthesis due to a deficiency of glucosamine phosphate acetyltransferaseE J Neufeld, I Pastan
Hematology/Oncology Clinics of North America|January 29, 1999
Hemophilia. A new approach to an old diseaseD DiMichele, E J Neufeld
The Journal of Biological Chemistry|February 25, 1983
Arachidonate release and phosphatidic acid turnover in stimulated human plateletsE J Neufeld, P W Majerus
Biochemical and Biophysical Research Communications|January 15, 1993
Sequence-specific binding of HMG-I (Y) to the proximal promoter of the gp91-phox geneD G Skalnik, E J Neufeld
Haemophilia : the Official Journal of the World Federation of Hemophilia|April 10, 2015
Transition considerations for extended half-life factor productsS E Croteau, E J Neufeld
Haemophilia : the Official Journal of the World Federation of Hemophilia|May 6, 2015
Author's response: 'Transition considerations for extended half-life factor products'S E Croteau, E J Neufeld
Biochemical and Biophysical Research Communications|September 16, 1992
Sequence-specific binding of HMG-I(Y) to the proximal promoter of the gp91-phox geneD G Skalnik, E J Neufeld
Haemophilia : the Official Journal of the World Federation of Hemophilia|October 15, 2014
Correlation between dispensed and prescribed doses of factor products for bleeding disorders: can a small, centre-based pharmacy hit the mark?S E Croteau, K Saxena, E J Neufeld
Pageof 8